Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sex differences in autoimmune disease.
Effects of dimethyl fumarate on neuroprotection and immunomodulation.
TECFIDERA prescribing information
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.
Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient.
Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
IL-2Rβγ-signaling contributes to regulatory T cell maintenance and stability in daclizumab HYP-treated RRMS patients
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
Webinar: Solutions for Genome Editing: TALEN, CRISPR, & Safe Harbor Integration
Oral BG-12 (dimethyl fumarate) significantly reduced multiple sclerosis (MS) relapses and disability progression in DEFINE Phase 3 clinical trial
Sex differences in autoimmune diseases.
Optical coherence tomography reflects brain atrophy in MS: A four year study.
Clinical Trials
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Episode 30 with Dr. Seema Tiwari-Woodruff on estrogenic compounds and MS
Keystone Symposium: Gut Microbiota Modulation of Host Physiology: The Search for Mechanism
Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
The neuroendocrine axis in patients with multiple sclerosis.
MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.
American Academy of Neurology: Breakthroughs in Neurology
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
Pages
« first
‹ previous
…
52
53
54
55
56
57
58
59
60
…
next ›
last »